{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T04:15:41Z","timestamp":1768536941557,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>Both hyperglycaemia and large glycaemic variability are associated with worse outcomes in patients with Type 2 diabetes mellitus (T2DM), possibly causing sympatho-vagal imbalance and endothelial dysfunction. Continuous subcutaneous insulin injection (CSII) improves glycemic control compared to multiple daily insulin injections (MDI). We aimed to assess whether CSII may improve cardiac autonomic and vascular dilation function compared to MDI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We enrolled T2DM patients without cardiovascular disease with poor glycaemic control, despite optimized MDI therapy. Patients were randomized to continue MDI (with multiple daily peripheral glucose measurements) or CSII; insulin dose was adjusted to achieve optimal target ranges of blood glucose levels. Patients were studied at baseline and after 6 months by: 1) flow-mediated dilation (FMD) and nitrate-mediated dilation (NMD) of the brachial artery; 2) heart rate variability (HRV) by 24-hour ECG Holter monitoring (HM). 7-day continuous glucose monitoring (CGM) was performed in 9 and 8 patients of Group 1 and 2, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 21 patients were enrolled, 12 randomized to CSII (Group 1) and 9 to MDI (Group 2). The daily dose of insulin and Hb1AC did not differ significantly between the 2 groups, both at baseline and at follow-up. Glucose variability showed some significant improvement at follow-up in the whole population, but no differences were observed between the 2 groups. Both FMD and NMD, as well as HRV parameters, showed no significant differences between the 2 groups at 6-month follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In this randomized small study we show that, in T2DM patients, CSII achieves a similar medium-term glycemic control compared to MDI, without any adverse effect on the cardiovascular system.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12020-023-03651-w","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T08:02:54Z","timestamp":1704873774000},"page":"128-135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Insulin pump treatment vs. multiple daily insulin injections in patients with poorly controlled Type 2 diabetes mellitus: a comparison of cardiovascular effects"],"prefix":"10.1007","volume":"84","author":[{"given":"Saverio","family":"Tremamunno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Tartaglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Telesca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Felici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Mazzotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"De Vita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nello","family":"Cambise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonietta","family":"Belmusto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Pitocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2187-6653","authenticated-orcid":false,"given":"Gaetano Antonio","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,10]]},"reference":[{"key":"3651_CR1","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1007\/BF00399789","volume":"37","author":"K Dahl-J\u00f8rgensen","year":"1994","unstructured":"K. Dahl-J\u00f8rgensen, O. Brinchmann-Hansen, H.J. Bangstad, K.F. Hanssen, Blood glucose control and microvascular complications-what do we do now? Diabetologia 37, 1172\u20131177 (1994). https:\/\/doi.org\/10.1007\/BF00399789","journal-title":"Diabetologia"},{"key":"3651_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/s0889-8529(05)70323-6","volume":"25","author":"JS Skyler","year":"1996","unstructured":"J.S. Skyler, Diabetic complications. The importance of glucose control. Endocrinol. Metab. Clin. North Am. 25, 243\u2013254 (1996). https:\/\/doi.org\/10.1016\/s0889-8529(05)70323-6","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"3651_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijcard.2019.02.030","volume":"291","author":"A Avogaro","year":"2019","unstructured":"A. Avogaro, G.P. Fadini, Microvascular complications in diabetes: a growing concern for cardiologists. Int J. Cardiol. 291, 29\u201335 (2019). https:\/\/doi.org\/10.1016\/j.ijcard.2019.02.030","journal-title":"Int J. Cardiol."},{"key":"3651_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/2047487319878371","volume":"26","author":"E Dal Canto","year":"2019","unstructured":"E. Dal Canto, A. Ceriello, L. Ryd\u00e9n, M. Ferrini, T.B. Hansen, O. Schnell, E. Standl, J.W. Beulens, Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications. Eur. J. Prev. Cardiol. 26, 25\u201332 (2019). https:\/\/doi.org\/10.1177\/2047487319878371","journal-title":"Eur. J. Prev. Cardiol."},{"key":"3651_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2337\/diab.46.2.271","volume":"46","author":"The Diabetes Control and Complications Trial Research Group","year":"1997","unstructured":"The Diabetes Control and Complications Trial Research Group, Hypoglycemia in the diabetes control and complications trial. Diabetes 46, 271\u2013286 (1997)","journal-title":"Diabetes"},{"key":"3651_CR6","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.2337\/dc11-2054","volume":"35","author":"RG McCoy","year":"2012","unstructured":"R.G. McCoy, H.K. Van Houten, J.Y. Ziegenfuss et al. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care 35, 1897\u20131901 (2012). https:\/\/doi.org\/10.2337\/dc11-2054","journal-title":"Diabetes Care"},{"key":"3651_CR7","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.2337\/dc14-0405","volume":"37","author":"TW Lung","year":"2014","unstructured":"T.W. Lung, D. Petrie, W.H. Herman et al. Severe hypoglycemia and mortality after cardiovascular events for Type 1 diabetic patients in Sweden. Diabetes Care 37, 2974\u20132981 (2014). https:\/\/doi.org\/10.2337\/dc14-0405","journal-title":"Diabetes Care"},{"key":"3651_CR8","first-page":"203","volume":"14","author":"F Infusino","year":"2010","unstructured":"F. Infusino, D. Pitocco, F. Zaccardi, G. Scalone, I. Coviello, R. Nerla, R. Mollo, A. Sestito, A. Di Monaco, L. Barone, C. Pisanello, G. Ghirlanda, G.A. Lanza, F. Crea, Low glucose blood levels are associated with abnormal cardiac sympatho-vagal balance in Type 2 diabetic patients with coronary artery disease. Eur. Rev. Med Pharm. Sci. 14, 203\u2013207 (2010)","journal-title":"Eur. Rev. Med Pharm. Sci."},{"key":"3651_CR9","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.2337\/dc12-1127","volume":"36","author":"D Pitocco","year":"2013","unstructured":"D. Pitocco, F. Zaccardi, F. Infusino, R. Nerla, G. Ghirlanda, G.A. Lanza, Comment on: Koivikko et al. Autonomic cardiac regulation during spontaneous nocturnal hypoglycemia in patients with Type 1 diabetes. Diabetes Care 2012;35:1585-1590. Diabetes Care 36, e19 (2013). https:\/\/doi.org\/10.2337\/dc12-1127","journal-title":"Diabetes Care"},{"key":"3651_CR10","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/eurheartj\/ehm018","volume":"28","author":"GA Lanza","year":"2007","unstructured":"G.A. Lanza, D. Pitocco, E.P. Navarese, A. Sestito, G.A. Sgueglia, A. Manto, F. Infusino, T. Musella, G. Ghirlanda, F. Crea, Association between cardiac autonomic dysfunction and inflammation in Type 1 diabetic patients: effect of beta-blockade. Eur. Heart J. 28, 814\u2013820 (2007). https:\/\/doi.org\/10.1093\/eurheartj\/ehm018","journal-title":"Eur. Heart J."},{"key":"3651_CR11","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/dmrr.1239","volume":"27","author":"V Spallone","year":"2011","unstructured":"V. Spallone, D. Ziegler, R. Freeman, L. Bernardi, S. Frontoni, R. Pop-Busui, M. Stevens, P. Kempler, J. Hilsted, S. Tesfaye, P. Low, P. Valensi; Toronto Consensus Panel on Diabetic Neuropathy, Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab. Res Rev. 27, 639\u2013653 (2011). https:\/\/doi.org\/10.1002\/dmrr.1239","journal-title":"Diabetes Metab. Res Rev."},{"key":"3651_CR12","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1136\/hrt.2005.070714","volume":"92","author":"GA Lanza","year":"2006","unstructured":"G.A. Lanza, D. Cianflone, A.G. Rebuzzi et al. Prognostic value of ventricular arrhythmias and heart rate variability in patients with unstable angina. Heart 92, 1055\u20131063 (2006). https:\/\/doi.org\/10.1136\/hrt.2005.070714","journal-title":"Heart"},{"key":"3651_CR13","doi-asserted-by":"publisher","first-page":"e3215","DOI":"10.1002\/dmrr.3215","volume":"36","author":"A Villano","year":"2020","unstructured":"A. Villano, E. Mencarelli, V. Melita, A. Rizzi, P. Lamendola, A. De Vita, L. Manfredonia, S.E. Ravenna, D. Pitocco, G.A. Lanza, F. Crea, Endothelial dysfunction and cardiovascular outcome in asymptomatic patients with Type 2 diabetes: A pilot study. Diabetes Metab. Res Rev. 36, e3215 (2020). https:\/\/doi.org\/10.1002\/dmrr.3215","journal-title":"Diabetes Metab. Res Rev."},{"key":"3651_CR14","doi-asserted-by":"publisher","first-page":"e3484","DOI":"10.1002\/dmrr.3484","volume":"38","author":"S Tremamunno","year":"2022","unstructured":"S. Tremamunno, A. De Vita, A. Villano, V. Melita, G. Ingrasciotta, E. Ruscio, M. Filice, A. Bisignani, S.E. Ravenna, L. Tartaglione, G.E. Rizzo, M. Di Leo, T. Felici, D. Pitocco, G.A. Lanza, Relation of endothelial and cardiac autonomic function with left ventricle diastolic function in patients with Type 2 diabetes mellitus. Diabetes Metab. Res Rev. 38, e3484 (2022). https:\/\/doi.org\/10.1002\/dmrr.3484","journal-title":"Diabetes Metab. Res Rev."},{"key":"3651_CR15","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.3390\/biomedicines10092274","volume":"10","author":"T Salvatore","year":"2022","unstructured":"T. Salvatore, R. Galiero, A. Caturano, E. Vetrano, G. Loffredo, L. Rinaldi, C. Catalini, K. Gjeloshi, G. Albanese, A. Di Martino, G. Docimo, C. Sardu, R. Marfella, F.C. Sasso, Coronary microvascular dysfunction in diabetes mellitus: pathogenetic mechanisms and potential therapeutic options. Biomedicines 10, 2274 (2022). https:\/\/doi.org\/10.3390\/biomedicines10092274","journal-title":"Biomedicines"},{"key":"3651_CR16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.7326\/0003-4819-157-5-201209040-00508","volume":"157","author":"HC Yeh","year":"2012","unstructured":"H.C. Yeh, T.T. Brown, N. Maruthur, P. Ranasinghe, Z. Berger, Y.D. Suh, L.M. Wilson, E.B. Haberl, J. Brick, E.B. Bass, S.H. Golden, Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann. Intern Med 157, 336\u2013347 (2012). https:\/\/doi.org\/10.7326\/0003-4819-157-5-201209040-00508","journal-title":"Ann. Intern Med"},{"issue":"May","key":"3651_CR17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2337\/dc16-2201","volume":"40","author":"JC Pickup","year":"2017","unstructured":"J.C. Pickup, Y. Reznik, A.J. Sutton, Glycemic control during continuous subcutaneous insulin infusion versus multiple daily insulin injections in Type 2 diabetes: individual patient data meta-analysis and meta-regression of randomized controlled trials. Diabetes Care 40(May), 715\u2013722 (2017). https:\/\/doi.org\/10.2337\/dc16-2201","journal-title":"Diabetes Care"},{"key":"3651_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4093\/dmj.2015.39.4.273","volume":"39","author":"S Suh","year":"2015","unstructured":"S. Suh, J.H. Kim, Glycemic variability: how do we measure it and why is it important? Diabetes Metab. J. 39, 273\u2013282 (2015). https:\/\/doi.org\/10.4093\/dmj.2015.39.4.273","journal-title":"Diabetes Metab. J."},{"key":"3651_CR19","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1177\/1932296818758105","volume":"12","author":"AM G\u00f3mez","year":"2018","unstructured":"A.M. G\u00f3mez, O.M. Mu\u00f1oz, A. Marin, M.C. Fonseca, M. Rondon, M.A. Robledo G\u00f3mez, A. Sanko, D. Lujan, M. Garc\u00eda-Jaramillo, F.M. Le\u00f3n Vargas, Different Indexes of Glycemic Variability as Identifiers of Patients with Risk of Hypoglycemia in Type 2 Diabetes Mellitus. J. Diabetes Sci. Technol. 12, 1007\u20131015 (2018). https:\/\/doi.org\/10.1177\/1932296818758105","journal-title":"J. Diabetes Sci. Technol."},{"key":"3651_CR20","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"T. Battelino, T. Danne, R.M. Bergenstal et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care 42, 1593\u20131603 (2019). https:\/\/doi.org\/10.2337\/dci19-0028","journal-title":"Diabetes Care"},{"key":"3651_CR21","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S0002-8703(03)00097-8","volume":"145","author":"MD Faulx","year":"2003","unstructured":"M.D. Faulx, A.T. Wright, B.D. Hoit, Detection of endothelial dysfunction with brachial artery ultrasound scanning. Am. Heart J. 145, 943\u2013951 (2003). https:\/\/doi.org\/10.1016\/S0002-8703(03)00097-8","journal-title":"Am. Heart J."},{"key":"3651_CR22","doi-asserted-by":"publisher","first-page":"H2","DOI":"10.1152\/ajpheart.00471.2010","volume":"300","author":"DH Thijssen","year":"2011","unstructured":"D.H. Thijssen, M.A. Black, K.E. Pyke et al. Assessment of flow\u2010mediated dilation in humans: a methodological and physiological guideline. Am. J. Physiol. Heart Circ. Physiol. 300, H2\u2013H12 (2011). https:\/\/doi.org\/10.1152\/ajpheart.00471.2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"3651_CR23","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1097\/HJH.0b013e328353f222","volume":"30","author":"L Ghiadoni","year":"2012","unstructured":"L. Ghiadoni, F. Faita, M. Salvetti, C. Cordiano, A. Biggi, M. Puato, A. Di Monaco, L. De Siati, M. Volpe, G. Ambrosio, V. Gemignani, M.L. Muiesan, S. Taddei, G.A. Lanza, F. Cosentino, Assessment of flow-mediated dilation reproducibility: a nationwide multicenter study. J. Hypertens. 30, 1399\u20131405 (2012). https:\/\/doi.org\/10.1097\/HJH.0b013e328353f222","journal-title":"J. Hypertens."},{"key":"3651_CR24","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1093\/eurheartj\/ehz350","volume":"40","author":"DHJ Thijssen","year":"2019","unstructured":"D.H.J. Thijssen, R.M. Bruno, A.C.C.M. van Mil, S.M. Holder, F. Faita, A. Greyling, P.L. Zock, S. Taddei, J.E. Deanfield, T. Luscher, D.J. Green, L. Ghiadoni, Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. Eur. Heart J. 40, 2534\u20132547 (2019). https:\/\/doi.org\/10.1093\/eurheartj\/ehz350","journal-title":"Eur. Heart J."},{"key":"3651_CR25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1542-474X.2005.10202.x","volume":"10","author":"B Del Mar","year":"2005","unstructured":"B. Del Mar, The history of clinical Holter Monitoring. Ann. Noninvasive Electrocardiol. 10, 226\u2013230 (2005). https:\/\/doi.org\/10.1111\/j.1542-474X.2005.10202.x","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"3651_CR26","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.CIR.93.5.1043","volume":"93","author":"Heart rate variability: standards of measurement, physiological interpretation and clinical use","year":"1996","unstructured":"Heart rate variability: standards of measurement, physiological interpretation and clinical use, Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 93, 1043\u20131065 (1996)","journal-title":"Circulation"},{"key":"3651_CR27","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/europace\/euv015","volume":"17","author":"R Sassi","year":"2015","unstructured":"R. Sassi, S. Cerutti, F. Lombardi, M. Malik, H.V. Huikuri, C.K. Peng, G. Schmidt, Y. Yamamoto, Advances in heart rate variability signal analysis: joint position statement by the e-Cardiology ESC Working Group and the European Heart Rhythm Association co-endorsed by the Asia Pacific Heart Rhythm Society. Europace 17, 1341\u20131353 (2015). https:\/\/doi.org\/10.1093\/europace\/euv015","journal-title":"Europace"},{"key":"3651_CR28","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.2337\/db17-0294","volume":"66","author":"S Costantino","year":"2017","unstructured":"S. Costantino, F. Paneni, R. Battista, L. Castello, G. Capretti, S. Chiandotto, L. Tanese, G. Russo, D. Pitocco, G.A. Lanza, M. Volpe, T.F. L\u00fcscher, F. Cosentino, Impact of glycemic variability on chromatin remodeling, oxidative stress, and endothelial dysfunction in patients with Type 2 Diabetes and with target HbA1c levels. Diabetes 66, 2472\u20132482 (2017). https:\/\/doi.org\/10.2337\/db17-0294","journal-title":"Diabetes"},{"key":"3651_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.amjcard.2012.08.049","volume":"111","author":"G Careri","year":"2013","unstructured":"G. Careri, R. Nerla, A. Di Monaco, G. Russo, A. Stazi, A. Villano, A. Sestito, G.A. Lanza, F. Crea, Clinical correlates and prognostic value of flow mediated dilation in patients with non-ST segment elevation acute coronary syndromes. Am. J. Cardiol. 111, 51\u201357 (2013). https:\/\/doi.org\/10.1016\/j.amjcard.2012.08.049","journal-title":"Am. J. Cardiol."},{"key":"3651_CR30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12933-022-01598-2","volume":"21","author":"C Di Mario","year":"2022","unstructured":"C. Di Mario, S. Genovese, G.A. Lanza, E. Mannucci, G. Marenzi, E. Sciatti, D. Pitocco; Expert Panel Group, Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus. Cardiovasc Diabetol. 21, 164 (2022). https:\/\/doi.org\/10.1186\/s12933-022-01598-2","journal-title":"Cardiovasc Diabetol."},{"key":"3651_CR31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1055\/s-0028-1119405","volume":"117","author":"M Monami","year":"2009","unstructured":"M. Monami, C. Lamanna, N. Marchionni, E. Mannucci, Continuous subcutaneous insulin infusion versus multiple daily insulin injections in Type 2 diabetes: a meta-analysis. Exp. Clin. Endocrinol. Diabetes 117, 220\u2013222 (2009). https:\/\/doi.org\/10.1055\/s-0028-1119405","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"3651_CR32","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1210\/jc.2008-1415","volume":"94","author":"MM Fatourechi","year":"2009","unstructured":"M.M. Fatourechi, Y.C. Kudva, M.H. Murad, M.B. Elamin, C.C. Tabini, V.M. Montori, Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J. Clin. Endocrinol. Metab. 94, 729\u2013740 (2009). https:\/\/doi.org\/10.1210\/jc.2008-1415","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3651_CR33","first-page":"1","volume":"9","author":"Medical Advisory Secretariat","year":"2009","unstructured":"Medical Advisory Secretariat, Continuous subcutaneous insulin infusion (CSII) pumps for Type 1 and Type 2 adult diabetic populations: an evidence-based analysis. Ont. Health Technol. Assess. Ser. 9, 1\u201358 (2009)","journal-title":"Ont. Health Technol. Assess. Ser."},{"key":"3651_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12020-016-1039-x","volume":"55","author":"K Benkhadra","year":"2017","unstructured":"K. Benkhadra, F. Alahdab, S.U. Tamhane, R.G. McCoy, L.J. Prokop, M.H. Murad, Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with Type 1 diabetes: a systematic review and meta-analysis. Endocrine 55, 77\u201384 (2017). https:\/\/doi.org\/10.1007\/s12020-016-1039-x","journal-title":"Endocrine"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03651-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03651-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03651-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T02:08:48Z","timestamp":1712110128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03651-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,10]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["3651"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03651-w","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,10]]},"assertion":[{"value":"23 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Aims and methods of the study were clearly discussed with potentially eligible patients, who provided formal written informed consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The study protocol was drawn up in accordance with the requirements of Good Clinical Practice of the European Union and the current revision of the Declaration of Helsinki and was approved by the Ethics Committee of our Institution.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}